Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
METamycin
- Development stage
- Unknown
- Lead developer
- Kyowa Kirin
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
METamycin (also known as OC136) is an investigational antifungal eye drop formulation developed by Nanomerics for the treatment of fungal keratitis. The drug utilizes Nanomerics' proprietary Molecular Envelope Technology (MET) nanoparticle platform to deliver a small molecule antifungal agent. The MET nanoparticles are designed to improve drug penetration into fungal biofilms and enhance delivery to the cornea, addressing significant unmet needs in fungal keratitis treatment where current therapies are limited by poor bioavailability and frequent dosing requirements. While the specific active ingredient has not been explicitly confirmed by the company, published research suggests it likely utilizes amphotericin B or a similar potent antifungal agent. The program has completed Phase 1 development.
- Other names
- METamycin
02
Targets
DNA
Beyond the preview
Go deeper on METamycin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on METamycin.